Form 8-K - Current report:
SEC Accession No. 0001193125-24-203149
Filing Date
2024-08-20
Accepted
2024-08-20 06:04:00
Documents
13
Period of Report
2024-08-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d867905d8k.htm   iXBRL 8-K 23582
  Complete submission text file 0001193125-24-203149.txt   141211

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240820.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240820_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240820_pre.xml EX-101.PRE 10807
16 EXTRACTED XBRL INSTANCE DOCUMENT d867905d8k_htm.xml XML 3533
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 241222531
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)